Occam Crest Management
Occam Crest Management reported 25 stocks worth $181M in its 13F filing for Q2 2026, filed Aug 14, 2026. Its largest holdings are TGTX (12.5%), PGEN (10.8%) and NESR (8.9%). Compared with Q1 2026, the fund opened new positions in CMPS, RDDT and MGNI, added to FTAI, SANM and LYFT, trimmed TGTX, PGEN and NESR and sold out of WLK, DOCS and GHRS.
Holdings
| # | Stock | Value | Weight | Shares | Change | Shares, 4 qtrs | Held |
|---|---|---|---|---|---|---|---|
| 1 |  TGTX TG Therapeutics Inc | $22.7M | 12.5% | 425K | −152K (−26%) | 4 of 4 | |
| 2 |  PGEN Precigen Inc | $19.7M | 10.8% | 3.6M | −663K (−16%) | 4 of 4 | |
| 3 |  NESR National Energy Services Reu | $16.1M | 8.9% | 658K | −15K (−2%) | 4 of 4 | |
| 4 |  FTAI Ftai Aviation Ltd | $14.8M | 8.2% | 75K | +10K (+15%) | 4 of 4 | |
| 5 |  SANM Sanmina Corporation | $12.9M | 7.1% | 79K | +18K (+30%) | 3 of 4 | |
| 6 |  FOUR SHIFT4 Pmts Inc | $11.3M | 6.2% | 201K | −17K (−8%) | 4 of 4 | |
| 7 |  LYFT Lyft Inc | $8M | 4.4% | 516K | +20K (+4%) | 4 of 4 | |
| 8 |  CMPS Compass Pathways PLC | $7.7M | 4.3% | 710K | New position | 1 of 4 | |
| 9 |  NVCT Nuvectis Pharma Inc | $7.4M | 4.1% | 357K | −50K (−12%) | 4 of 4 | |
| 10 |  AXSM Axsome Therapeutics Inc | $6.8M | 3.7% | 30K | −4,814 (−14%) | 4 of 4 |
Positions at Jun 30, 2026, as reported. Change is against the fund's Q1 2026 filing; weight is the share of the fund's reported stocks.
Sold out
held in Q1 2026, gone in Q2 2026| Stock | Value last quarter | Shares sold |
|---|---|---|
CLEAR CHANNEL OUTDOOR HLDGS | $5.5M | 2.3M |
TALKSPACE INC | $4M | 770K |
 WLK Westlake Corporation | $3.4M | 29K |
 DOCS Doximity Inc | $1.2M | 52K |
 GHRS GH Research PLC | $1.1M | 80K |
🔒 Free account: see all 8.
Options
valued at the underlying shares| Stock | Type | Value | Shares | Change |
|---|---|---|---|---|
NVCT Nuvectis Pharma Inc | Call | $5.2M | 4,800 | +4,800 |
 BLDR Builders Firstsource Inc | Call | $2.5M | 36K | +35,500 |
 USO United Sts Oil FD LP | Call | $1.6M | 745 | +745 |
 OEF Iwm 270115P00240000 | Put | $834K | 300 | +300 |
 IWF Ishares TR | Put | $539K | 750 | +750 |
🔒 Free account: see all 8.
Reported value
last 4 quartersThe value of the US stocks the fund reported, at quarter end prices. It moves with the market as well as with buying and selling.
Filings for Q2 2026
straight from the SEC| Filed | Form | Quarter | |
|---|---|---|---|
| Aug 14, 2026 | 13F-HR | Q2 2026 | SEC filing ↗ |
Other superinvestors
All hedge fund holdings →Occam Crest Management 13F FAQ
What does Occam Crest Management own?
Occam Crest Management reported 25 stocks worth $181M in its 13F filing for Q2 2026, filed Aug 14, 2026. Its largest holdings are TGTX (12.5%), PGEN (10.8%) and NESR (8.9%). The table above lists every position in the filing (the top 10 without an account).
What did Occam Crest Management buy and sell in Q2 2026?
Compared with Q1 2026: 5 new positions, 4 added to, 15 trimmed and 8 sold out. New positions include CMPS, RDDT and MGNI. It sold all of WLK, DOCS and GHRS.
When will Occam Crest Management file its next 13F?
Holdings as of Sep 30, 2026 are due by Nov 16, 2026. The filing appears on this page within minutes of reaching the SEC.
How much is Occam Crest Management's portfolio worth?
The Q2 2026 filing reports $181M in US stocks ($193M including options). That leaves out cash, bonds, short positions and most foreign holdings, so the fund's total assets are usually larger.
For informational and educational purposes only. Not investment advice, and not a recommendation to buy or sell any security. Holdings come from the fund's SEC Form 13F filings as reported and show positions at the end of the quarter, up to 45 days before the filing. The fund may have changed its positions since. A 13F leaves out short positions, cash, bonds and most foreign holdings. See all hedge fund holdings.